Skip navigation
Skip navigation

Etanercept in severe active rheumatoid arthritis: first Australian experience

Perera, L Chandima; Tymms, Kathleen; Wilson, B J; Shadbolt, Bruce; Brook, A S; Dorai-Raj, Anna; Khoo, Ken


Background: Etanercept reduces disease activity in adults with chronic rheumatoid arthritis (RA) who are resistant to other therapies. Medicare Australia Pharmaceutical Benefit Scheme subsidized treatment (since August 2003) restricts etanercept availability to a most drug-resistant RA population. The aim of the study was to assess the efficacy of etanercept in this unique group after 12 months of therapy. Methods: A prospective study of the first 50 consecutive private practice, adult RA...[Show more]

CollectionsANU Research Publications
Date published: 2006
Type: Journal article
Source: Internal Medicine Journal
DOI: 10.1111/j.1445-5994.2006.01170.x


File Description SizeFormat Image
01_Perera_Etanercept_in_severe_active_2006.pdf123.34 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator